Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 1, Human | 5 | 2017 | 64 | 1.310 |
Why?
|
| Virus Replication | 4 | 2016 | 318 | 0.840 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2017 | 5 | 0.660 |
Why?
|
| Thyroid Hormones | 2 | 2017 | 35 | 0.660 |
Why?
|
| Triiodothyronine | 2 | 2016 | 36 | 0.560 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 534 | 0.540 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 189 | 0.520 |
Why?
|
| Histones | 1 | 2017 | 194 | 0.490 |
Why?
|
| Virus Diseases | 1 | 2016 | 27 | 0.490 |
Why?
|
| Neuroendocrine Cells | 1 | 2014 | 4 | 0.450 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 274 | 0.360 |
Why?
|
| Herpes Zoster | 2 | 2021 | 12 | 0.290 |
Why?
|
| Thymidine Kinase | 2 | 2017 | 9 | 0.250 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2021 | 3 | 0.180 |
Why?
|
| Cell Line | 2 | 2016 | 1416 | 0.180 |
Why?
|
| Neurons | 2 | 2016 | 1246 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 2 | 2016 | 207 | 0.150 |
Why?
|
| Retinoid X Receptors | 1 | 2017 | 12 | 0.140 |
Why?
|
| Binding Sites | 2 | 2017 | 670 | 0.140 |
Why?
|
| Response Elements | 1 | 2017 | 55 | 0.140 |
Why?
|
| Point Mutation | 1 | 2017 | 98 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2017 | 633 | 0.130 |
Why?
|
| 4-Butyrolactone | 1 | 2016 | 12 | 0.130 |
Why?
|
| Herpes Simplex | 1 | 2016 | 19 | 0.130 |
Why?
|
| Virus Cultivation | 1 | 2016 | 7 | 0.130 |
Why?
|
| Prostate | 1 | 2017 | 152 | 0.120 |
Why?
|
| Poisson Distribution | 1 | 2016 | 44 | 0.120 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 6 | 0.120 |
Why?
|
| Chromatin | 1 | 2017 | 179 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 30 | 0.120 |
Why?
|
| Membrane Potentials | 1 | 2016 | 221 | 0.120 |
Why?
|
| Virion | 1 | 2016 | 73 | 0.120 |
Why?
|
| Immediate-Early Proteins | 1 | 2016 | 50 | 0.120 |
Why?
|
| Base Sequence | 1 | 2017 | 997 | 0.120 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1066 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 90 | 0.110 |
Why?
|
| Viral Load | 1 | 2016 | 344 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2016 | 203 | 0.110 |
Why?
|
| Protein Binding | 1 | 2017 | 1076 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2014 | 115 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 2598 | 0.100 |
Why?
|
| Algorithms | 1 | 2016 | 508 | 0.100 |
Why?
|
| Humans | 7 | 2021 | 42163 | 0.090 |
Why?
|
| Butyrylcholinesterase | 1 | 2010 | 5 | 0.080 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2010 | 44 | 0.080 |
Why?
|
| Alkaloids | 1 | 2010 | 46 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2017 | 2111 | 0.070 |
Why?
|
| Vero Cells | 2 | 2016 | 109 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2021 | 733 | 0.060 |
Why?
|
| Herpesvirus 3, Human | 1 | 2021 | 13 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 37 | 0.040 |
Why?
|
| Male | 2 | 2017 | 22779 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 82 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2016 | 36 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2016 | 75 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 254 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 148 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 649 | 0.030 |
Why?
|
| Animals | 3 | 2016 | 16695 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2016 | 426 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2015 | 960 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1054 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1266 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 1143 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1516 | 0.020 |
Why?
|
| Bryozoa | 1 | 2010 | 1 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 98 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2010 | 166 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 491 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2010 | 183 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2803 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 2485 | 0.020 |
Why?
|
| Child | 1 | 2015 | 3381 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4936 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 5950 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 7982 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 972 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 11819 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 13458 | 0.010 |
Why?
|
| Female | 1 | 2015 | 24018 | 0.010 |
Why?
|